Showing results (91-100 of 221) with videos related to
Sort By:
Pageof 23
Medrxiv : the Preprint Server for Health Sciences|February 26, 2024
Vaporized Cannabis versus Placebo for Acute Migraine: A Randomized Controlled TrialNathaniel M Schuster, Mark S Wallace, Thomas D Marcotte, et al.Scandinavian Journal of Pain|February 5, 2021
Health-related quality of life in tension-type headache: a population-based studySait Ashina, Dawn C Buse, Jakob B Bjorner, et al.Journal of Patient-Reported Outcomes|December 18, 2021
Combining patient reported outcomes and EHR data to understand population level treatment needs: correcting for selection bias in the migraine signature studyWalter F Stewart, Xiaowei Yan, Alice Pressman, et al.Pain and Therapy|March 13, 2024
Real-world Impact of Fremanezumab on Migraine-Related Health Care Resource Utilization in Patients with Comorbidities, Acute Medication Overuse, and/or Unsatisfactory Prior Migraine Preventive ResponseDawn C Buse, Lynda J Krasenbaum, Michael J Seminerio, et al.Headache|June 11, 2010
Rates and predictors of starting a triptan: results from the American Migraine Prevalence and Prevention StudyMarcelo E Bigal, Dawn C Buse, Ya-Ting Chen, et al.Headache|November 15, 2011
Depression and anxiety in episodic and chronic cluster headache: a pilot studyMatthew S Robbins, Rachel Bronheim, Richard B Lipton, et al.Current Pain and Headache Reports|April 11, 2012
Why HURT? A review of clinical instruments for headache managementDawn C Buse, C Mark Sollars, Timothy J Steiner, et al.Cephalalgia : an International Journal of Headache|October 12, 2014
The impact of chronic migraine: The Chronic Migraine Epidemiology and Outcomes (CaMEO) Study methods and baseline resultsAubrey Manack Adams, Daniel Serrano, Dawn C Buse, et al.The Journal of Headache and Pain|September 5, 2020
Improvements across a range of patient-reported domains with fremanezumab treatment: results from a patient survey studyDawn C Buse, Sanjay K Gandhi, Joshua M Cohen, et al.Headache|September 24, 2019
Discontinuation of Acute Prescription Medication for Migraine: Results From the Chronic Migraine Epidemiology and Outcomes (CaMEO) StudyRichard B Lipton, Susan Hutchinson, Jessica Ailani, et al.Pageof 23